DAPAGLIFLOZIN
breakthrough for type-2 diabetesFULL TECHNICAL AND REGULATORY SUPPORT
DAPAGLIFLOZIN (CAS 461432-26-8), also known as FORXIGA® and FARXIGA®, is a prescription medication used to control blood sugar levels in people with type-2 diabetes. Dapagliflozin works in the kidney to block a protein called SGLT2, which is in charge of delivering glucose into the bloodstream.
THERAPEUTIC INDICATION: ANTI-DIABETES
DAPAGLIFLOZIN is used for the treatment of type-2 diabetes. It is taken as film-coated tablets of 10mg.
MARKET INFORMATION
Originator: BRISTOL-MYERS SQUIBB in partnership with ASTRA ZENECA
Trade names: FORXIGA®, FARXIGA®
YOUR ADVANTAGES
- Reliable supply guaranteed
- Short lead time with full technical and regulatory support
This article uses material from Wikipedia, which is released under the Creative Commons Attribution-Share-Alike License 3.0.